Motion to Proceed to S.3187, FDA

The Senate is considering the motion to proceed to S.3187, A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

The time until 10:30am is equally divided and controlled between the two Leaders or their designees, with the Republicans controlling the first half and the Majority controlling the second half.